It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Patient-ventilator asynchronies can be detected by close monitoring of ventilator screens by clinicians or through automated algorithms. However, detecting complex patient-ventilator interactions (CP-VI), consisting of changes in the respiratory rate and/or clusters of asynchronies, is a challenge. Sample Entropy (SE) of airway flow (SE-Flow) and airway pressure (SE-Paw) waveforms obtained from 27 critically ill patients was used to develop and validate an automated algorithm for detecting CP-VI. The algorithm’s performance was compared versus the gold standard (the ventilator’s waveform recordings for CP-VI were scored visually by three experts; Fleiss’ kappa = 0.90 (0.87–0.93)). A repeated holdout cross-validation procedure using the Matthews correlation coefficient (MCC) as a measure of effectiveness was used for optimization of different combinations of SE settings (embedding dimension, m, and tolerance value, r), derived SE features (mean and maximum values), and the thresholds of change (Th) from patient’s own baseline SE value. The most accurate results were obtained using the maximum values of SE-Flow (m = 2, r = 0.2, Th = 25%) and SE-Paw (m = 4, r = 0.2, Th = 30%) which report MCCs of 0.85 (0.78–0.86) and 0.78 (0.78–0.85), and accuracies of 0.93 (0.89–0.93) and 0.89 (0.89–0.93), respectively. This approach promises an improvement in the accurate detection of CP-VI, and future study of their clinical implications.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Universitat Autònoma de Barcelona, Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain (GRID:grid.7080.f); Instituto de Salud Carlos III, Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
2 Universitat Autònoma de Barcelona, Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain (GRID:grid.7080.f); Instituto de Salud Carlos III, Biomedical Research Networking Center in Respiratory Disease (CIBERES), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat de Barcelona, Facultat de Medicina, Barcelona, Spain (GRID:grid.5841.8) (ISNI:0000 0004 1937 0247)
3 BetterCare S.L, Sabadell, Spain (GRID:grid.5841.8)
4 Universitat Autònoma de Barcelona, Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain (GRID:grid.7080.f); Instituto de Salud Carlos III, Biomedical Research Networking Center in Respiratory Disease (CIBERES), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
5 Universitat Internacional de Catalunya , Department of Intensive Care, Fundació Althaia, Manresa, Spain (GRID:grid.410675.1) (ISNI:0000 0001 2325 3084)
6 Universitat de Lleida-IRBLLEIDA, Department of Basic Medical Sciences, Lleida, Spain (GRID:grid.15043.33) (ISNI:0000 0001 2163 1432)
7 Universitat Autònoma de Barcelona, Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain (GRID:grid.7080.f)
8 Instituto de Salud Carlos III, Biomedical Research Networking Center in Respiratory Disease (CIBERES), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); Universitat Internacional de Catalunya , Department of Intensive Care, Fundació Althaia, Manresa, Spain (GRID:grid.410675.1) (ISNI:0000 0001 2325 3084)
9 Universitat Autònoma de Barcelona, Critical Care Center, Hospital Universitari Parc Taulí, Institut d’Investigació i Innovació Parc Taulí I3PT, Sabadell, Spain (GRID:grid.7080.f); Instituto de Salud Carlos III, Biomedical Research Networking Center in Respiratory Disease (CIBERES), Madrid, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427); BetterCare S.L, Sabadell, Spain (GRID:grid.413448.e)




